(S1 (S (S (NP (NP (JJ Adenomatoid) (NN tumour)) (PP (IN of) (NP (DT the) (NN liver))))) (. .)))
(S1 (S (S (NP (NP (DT An) (JJ unusual) (JJ primary) (NN adenomatoid) (NN tumour)) (VP (VBG arising) (PP (IN in) (NP (DT the) (JJ normal) (NN liver))))) (VP (VBZ is) (VP (VBN described)))) (. .)))
(S1 (S (S (S (NP (NN Hepatectomy)) (VP (VBD was) (VP (VBN performed)))) (, ,) (CC and) (S (NP (DT the) (NN patient)) (VP (VBZ is) (ADJP (ADJP (JJ alive)) (CC and) (ADJP (JJ free)) (PP (IN of) (NP (NN disease) (CD 1) (NN year) (JJ postsurgery))))))) (. .)))
(S1 (S (S (ADVP (RB Grossly)) (, ,) (NP (DT the) (NN tumour)) (VP (VBD showed) (NP (NP (DT a) (JJ haemorrhagic) (NN cut) (NN surface)) (PP (IN with) (NP (JJ numerous) (JJ microcystic) (NNS structures)))))) (. .)))
(S1 (S (S (NP (JJ Histological) (NN examination)) (VP (VBD revealed) (NP (NP (ADJP (ADJP (JJ cystic)) (CC or) (ADJP (JJ angiomatoid))) (NNS spaces)) (PP (IN of) (NP (NP (JJ various) (NNS sizes)) (VP (VBN lined) (PP (IN by) (NP (ADJP (ADJP (JJ cuboidal)) (, ,) (ADJP (JJ low-columnar)) (, ,) (CC or) (ADJP (JJ flattened))) (NN epithelioid) (NNS cells))) (PP (IN with) (NP (NP (ADJP (VBN vacuolated)) (NN cytoplasm)) (CC and) (NP (NN round) (TO to) (NN oval) (NNS nuclei)))))))))) (. .)))
(S1 (S (S (NP (DT The) (JJ epithelioid) (NNS cells)) (VP (VBD were) (ADVP (RB entirely)) (VP (VBN supported) (PP (IN by) (NP (NP (NP (VBN proliferated) (NNS capillaries)) (CC and) (NP (NNS arteries))) (PP (ADVP (RB together)) (IN with) (NP (JJ collagenous) (NN stroma)))))))) (. .)))
(S1 (S (S (NP (JJ Immunohistochemical) (NNS studies)) (VP (VBD showed) (SBAR (IN that) (S (NP (DT the) (JJ epithelioid) (NNS cells)) (VP (VBD were) (ADJP (RB strongly) (JJ positive) (PP (IN for) (NP (NP (DT a) (JJ broad) (NN spectrum)) (PP (IN of) (NP (NP (NP (NNS cytokeratins)) (PRN (-LRB- -LRB-) (NP (NP (NN AE1/AE3)) (, ,) (NP (CD CAM5.2)) (, ,) (NP (JJ epithelial) (NN membrane) (NN antigen)) (CC and) (NP (NN cytokeratin) (CD 7))) (-RRB- -RRB-))) (CC and) (NP (NP (JJ mesothelial) (NNS markers)) (PRN (-LRB- -LRB-) (NP (NP (NN calretinin)) (, ,) (NP (NN Wilms) (POS ') (NN tumour) (CD 1)) (CC and) (NP (NN D2-40))) (-RRB- -RRB-))))))))))))) (. .)))
(S1 (S (S (NP (DT These) (NNS cells)) (VP (VBD were) (ADJP (JJ negative) (PP (IN for) (NP (NP (NN Hep) (NN par-1)) (, ,) (NP (JJ carcinoembryonic) (NN antigen)) (, ,) (NP (JJ neural) (NN cell) (NN adhesion) (NN molecule)) (, ,) (NP (NN CD34)) (, ,) (NP (NN CD31)) (CC and) (NP (NN HMB45))))))) (. .)))
(S1 (S (S (ADVP (RB Atypically)) (, ,) (NP (JJ abundant) (NNS capillaries)) (VP (VBD were) (VP (VBN observed)))) (: ;) (ADVP (RB however)) (, ,) (S (NP (NP (DT the) (JJ cystic) (NN proliferation)) (PP (IN of) (NP (NP (JJ epithelioid) (NNS cells)) (PP (IN with) (NP (NP (NP (NNS vacuoles)) (CC and) (NP (JJ immunohistochemical) (NN profile))) (PP (IN of) (NP (DT the) (NN epithelioid) (NN element)))))))) (VP (VBD were) (ADJP (JJ consistent) (PP (IN with) (NP (JJ hepatic) (JJ adenomatoid) (NN tumour)))))) (. .)))
